Cours Cell MedX Corp OTC Bulletin Board
Actions
US15115X1072
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2022 | 0,01 0,01 | CA 2023 | 0 0 | Capitalisation | 6,29 k 5,66 k |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | 1 135 153 669 x |
Dette nette 2022 | 592 k 533 k | Dette nette 2023 | 903 k 812 k | VE / CA 2023 | 329 116 944 x |
PER 2022 |
-9,01
x | PER 2023 |
-0,01
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 20,34% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24/11/14 |
George Adams
CHM | Chairman | 76 | 23/03/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/04/22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/06/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,77% | 49,18 Md | |
+1,00% | 42,11 Md | |
+50,47% | 40,37 Md | |
-5,26% | 28,85 Md | |
+13,68% | 26,09 Md | |
-22,99% | 18,71 Md | |
+8,22% | 13,26 Md | |
+32,41% | 12,32 Md | |
-1,62% | 11,99 Md |
- Bourse
- Actions
- Action CMXC
- Action